Published

Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Drugs and Drug Candidates
Date: 2026-08-12
Source: Crossref
DOI: 10.3390/ddc5030046
PubMed: Unavailable

Authors

Salgaço Mateus Kawata Farias David de Paulo Souza Mariela Zucolo de Sartoratto Adilson Bottino Flavia Barud Hernane da Silva Oliveira Fellipe Lopes de Medeiros Alexandra Ivo de Raimundo Breno Vilas Boas Nascimento Victor Hugo Galdino Taynah P.Silva Suédina M. L.Fook Marcus V. L.Sivieri Katia

Watch author

Derived topics and classifications

psilocybin psilocin Anxiety Pharmacology Mechanism of Action Animal Study In Vitro Study Microbiome Inflammation Immune Function In Vitro Study

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1016/j.neuroimage.2019.06.036 10.1016/j.drugpo.2021.103518 10.1080/03602532.2016.1278228 10.1097/00001756-199812010-00024 10.1007/s40262-017-0540-6 10.3325/cmj.2021.62.528 10.1021/acschemneuro.8b00186 10.1016/j.euroneuro.2013.12.006 10.1080/1355621021000005937 10.1016/s0731-7085(02)00278-9 10.1016/j.phrs.2024.107338 10.1021/acschemneuro.5c00418

Indexed papers citing this DOI

Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety2026-08-12

Related papers

Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15